Log in

6986 HeXun Biosciences Co Ltd TPEX · Taiwan

HeXun Biosciences Co (6986) news

HeXun Biosciences Co Ltd is a public biotech or pharmaceutical company listed on TPEX under the ticker 6986, recorded under Taiwan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest HeXun Biosciences Co news

We have not published a story on HeXun Biosciences Co yet. When there is news, it will appear here.

Questions about HeXun Biosciences Co

What is the ticker symbol of HeXun Biosciences Co?

HeXun Biosciences Co Ltd trades under the ticker 6986 on TPEX.

Where is HeXun Biosciences Co listed?

HeXun Biosciences Co Ltd is listed on TPEX.

Which country or territory is HeXun Biosciences Co listed under?

Our directory records HeXun Biosciences Co Ltd under Taiwan.

What does HeXun Biosciences Co do?

Our directory classifies HeXun Biosciences Co Ltd as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of HeXun Biosciences Co?

The ISIN recorded for HeXun Biosciences Co Ltd is TW0006986003.

Does aibio.space cover HeXun Biosciences Co?

aibio.space lists HeXun Biosciences Co Ltd among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to HeXun Biosciences Co?

Companies in our directory listed in the same country and business area as HeXun Biosciences Co: TFBS Bioscience, Bioptic, Anbogen Therapeutics, Shangya Technology Co, Medigen Vaccine Biologics, Pharmasaga Co..

Investor discussion: HeXun Biosciences Co

Members talk about HeXun Biosciences Co (6986). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TPEX:6986 on TradingView.

Listing details

HeXun Biosciences Co Ltd is a public biotech or pharmaceutical company listed on TPEX under the ticker 6986, recorded under Taiwan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
HeXun Biosciences Co Ltd
Ticker
6986
Listing
TPEX
Country or territory
Taiwan
Business scope
Biotechnology
ISIN
TW0006986003
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.